Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)

Autor:	Aynsley, Eleanor, Banner, Russel, Barnett, Gill, Cardale, Kate, Christian, Judith, Fresco, Lydia, Grant, Warren, Hartley, Andrew, Lester, James, McCloskey, Paula, Prestwich, Robin, Shenoy, Aditya, Thiagarajan, Sridhar, Wood, Katie, Thomson, David J., Slevin, Nick J., Baines, Helen, Betts, Guy, Bolton, Steve *, Evans, Mererid, Garcez, Kate *, Irlam, Joely, Lee, Lip *, Melillo, Nicola, Mistry, Hitesh, More, Elisabet, Nutting, Christopher, Price, James M., Schipani, Stefano, Sen, Mehmet, Yang, Huiqi, West, Catharine M.
Zdroj:	In International Journal of Radiation Oncology, Biology, Physics 1 July 2024 119(3):771-782
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu